Significance of PAK1/CREB Pathway in Lung Adenocarcinoma Oncogenesis

被引：1
|
作者：
Yoon, S. [1 ]
Chung, J. [1 ]
Kang, L. [1 ]
Ock, H. [1 ]
Seo, H. [1 ]
Kim, Y. [1 ]
机构：
[1] Pusan Natl Univ, Yangsan Hosp, Pulmonol, Yangsan Si, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
lung adenocarcinoma; PAK1; CREB;
D O I：
10.1016/j.jtho.2017.09.1935
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PUB072
引用
收藏
页码：S2389 / S2389
页数：1
相关论文
共 50 条
  • [1] Significance of KRAS/PAK1/Crk pathway in non-small cell lung cancer oncogenesis
    Mortazavi, Fariborz
    Lu, Jie
    Phan, Ryan
    Lewis, Michael
    Trinidad, Kenny
    Aljilani, Amir
    Pezeshkpour, Gholamhossein
    Tamanoi, Fuyuhiko
    BMC CANCER, 2015, 15
  • [2] Significance of KRAS/PAK1/Crk pathway in non-small cell lung cancer oncogenesis
    Fariborz Mortazavi
    Jie Lu
    Ryan Phan
    Michael Lewis
    Kenny Trinidad
    Amir Aljilani
    Gholamhossein Pezeshkpour
    Fuyuhiko Tamanoi
    BMC Cancer, 15
  • [3] Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells
    Li, Man-Yuan
    Zhang, Jiao
    Lu, Xiao
    Zhou, Dong
    Deng, Xu-Feng
    Liu, Quan-Xing
    Dai, Ji-Gang
    Zheng, Hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (01) : 41 - 54
  • [4] Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells
    Man-Yuan Li
    Jiao Zhang
    Xiao Lu
    Dong Zhou
    Xu-Feng Deng
    Quan-Xing Liu
    Ji-Gang Dai
    Hong Zheng
    Cancer Chemotherapy and Pharmacology, 2024, 93 : 41 - 54
  • [5] Effects of PAK1 on Proliferation, Migration, Apoptosis and Invasion of Hepatoma Cells through PAK1/ERK Pathway
    Zhao, Ruilian
    Gao, Ying
    Shen, Hongmei
    Guo, Lihua
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 86 (01) : 187 - 192
  • [6] ANKRD52 inhibited tumor metastasis through dephosphorylation of PAK1 in lung adenocarcinoma
    Lin, Yen-Fan
    Liu, Ying-Pu
    Lee, Ting-Fang
    Wu, Cheng-Wen
    CANCER RESEARCH, 2017, 77
  • [7] Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma
    Jin, Runsen
    Wang, Xinfeng
    Zang, Ruochuan
    Liu, Chengming
    Zheng, Sufei
    Li, Hecheng
    Sun, Nan
    He, Jie
    CANCER LETTERS, 2020, 483 : 46 - 58
  • [8] PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions
    Grebenova, Dana
    Holoubek, Ales
    Roselova, Pavla
    Obr, Adam
    Brodska, Barbora
    Kuzelova, Katerina
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions
    Dana Grebeňová
    Aleš Holoubek
    Pavla Röselová
    Adam Obr
    Barbora Brodská
    Kateřina Kuželová
    Scientific Reports, 9
  • [10] Targeting PAK1
    Semenova, Galina
    Chernoff, Jonathan
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2017, 45 : 79 - 88
12345